홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Ether hydrochloride → (2-Fluoro-4-methanesulfonyl-phenyl)-{6-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yloxy]-5-methyl-pyrimidin-4-yl}-amine

HRID 1174755
인쇄

반응식

HRID 1174755 반응식
Cl[C:2]1[N:7]=[CH:6][N:5]=[C:4]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([S:15]([CH3:18])(=[O:17])=[O:16])=[CH:11][C:10]=2[F:19])[C:3]=1[CH3:20].[CH:21]([C:24]1[N:28]=[C:27]([N:29]2[CH2:34][CH2:33][CH:32]([OH:35])[CH2:31][CH2:30]2)[O:26][N:25]=1)([CH3:23])[CH3:22].CC(C)([O-])C.[K+].Cl.CCOCC>C1COCC1.C(Cl)Cl>[F:19][C:10]1[CH:11]=[C:12]([S:15]([CH3:18])(=[O:17])=[O:16])[CH:13]=[CH:14][C:9]=1[NH:8][C:4]1[C:3]([CH3:20])=[C:2]([O:35][CH:32]2[CH2:33][CH2:34][N:29]([C:27]3[O:26][N:25]=[C:24]([CH:21]([CH3:23])[CH3:22])[N:28]=3)[CH2:30][CH2:31]2)[N:7]=[CH:6][N:5]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 10953452Ether hydrochlorideHCID 218977441-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OLHCID 23665647Potassium tert-butoxideHCID 86597362(6-Chloro-5-methyl-pyrimidin-4-yl)-(2-fluoro-4-methanesulfonyl-phenyl)-amine

생성물 1

HCID 59856820(2-Fluoro-4-methanesulfonyl-phenyl)-{6-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yloxy]-5-methyl-pyrimidin-4-yl}-amine
수율 30%

시약·촉매·용매 2

HCID 6344Dichloromethane용매HCID 8028Tetrahydrofuran용매

실험 절차

A mixture of (6-chloro-5-methyl-pyrimidin-4-yl)-(2-fluoro-4-methanesulfonyl-phenyl)-amine (HCl salt, 1.76 g, 5.0 mmol) and 1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-ol (1.05 g, 5.0 mmol) in anhydrous THF (10 mL) was treated with potassium t-butoxide (20 mL, 20 mmol), placed under inert atmosphere, and refluxed for 4 hours, at which point the reaction had stalled at 60% conversion. The reaction mixture was cooled, quenched with water (30 mL), and extracted with ether (2×50 mL). The combined organic extract was rinsed with water (20 mL), followed by brine (20 mL), and was dried over MgSO4. After solvent removal, the residue was rinsed with boiling ether (2×20 mL), and the combined rinses were set aside to cool. Crystallization yielded a white solid (91% pure by LCMS) which was triturated in hot ether and filtered hot to furnish Compound A93 as a white solid in >95% purity (731 mg, 30% yield). This material was taken up in CH2Cl2 (10 mL), to which was added 1 N HCl/ether (1.5 mL). Upon solvent removal, a light gray foam was obtained (800 mg): 1H NMR (DMSO-d6) δ 10.26 (brs, 1 H), 8.77 (s, 1 H), 8.22 (s, 1 H), 7.83-7.71 (m, 3 H), 5.33 (m, 1 H), 3.75 (m, 2 H), 3.57 (m, 2 H), 3.37 (s, 3 H), 2.83 (m, 1 H), 2.13 (s, 3 H), 2.04 (m, 2 H), 1.78 (m, 2 H), 1.20 (d, 6 H, J=6.9 Hz), MS m/z 491.2 (M+).

후처리

  1. temperaturerefluxed for 4 hours, at which
  2. temperatureThe reaction mixture was cooled
  3. customquenched with water (30 mL)
  4. extractionextracted with ether (2×50 mL)
  5. extractionThe combined organic extract
  6. washwas rinsed with water (20 mL)
  7. dry with materialwas dried over MgSO4
  8. customAfter solvent removal
  9. washthe residue was rinsed with boiling ether (2×20 mL)
  10. temperatureto cool
  11. customCrystallization
  12. customyielded a white solid (91% pure by LCMS) which
  13. customwas triturated in hot ether
  14. filtrationfiltered hot
  15. customto furnish Compound A93 as a white solid in >95% purity (731 mg, 30% yield)
  16. customUpon solvent removal
  17. customa light gray foam was obtained (800 mg)

출처 및 근거

ORD 기록
ord-33ed51a79cbb4251bc14d4a001ee6ef9
출처 데이터셋
uspto-grants-2010_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07838525B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트